SIREN (Sarscov2 Immunity & Reinfection EvaluatioN):
The impact of detectable anti SARS-COV2 antibody on the incidence of COVID-19 in healthcare workers
Southern Health R&D Department is working with Public Health England on an urgent public health Covid-19 (SARS-CoV2) research. The overall aim of the SIREN study is to determine if prior infection on Covid-19 provides future immunity to re-infection. The data collected will also help to inform on the effectiveness of any vaccine administered.
UPDATE (February 2021):
The study is now closed for participant recruitment. Thank you for your interest in the study.